Journals / Türk Oftalmoloji Dergisi / 2014 / Cilt: 44 - Sayı: 5

Familial exudative vitreoretinopathy: Follow-up and treatment results

Familyal eksudatif vitreoretinopati: Takip ve tedavi sonuçlarımız

Pages
370–373
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

These patients should be followed up throughout the life, and the essential treatment at the appropriate time can lead to partial visual recovery. (Turk J Ophthalmol 2014; 44: 370-3)

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: To report the follow-up and treatment results of cases with the diagnosis of familial exudative vitreoretinopathy (FEVR) in our clinic.
📊
Key Findings & Data:Materials and Methods: We retrospectively reviewed the records of 19 eyes of 10 cases of FEVR that were followed up and some of them were treated in our clinic.
💡
Conclusion & Impact:These patients should be followed up throughout the life, and the essential treatment at the appropriate time can lead to partial visual recovery. (Turk J Ophthalmol 2014; 44: 370-3)
🔬Design:Review & Systematic Survey
📍Scope:2014 Verileri
⚙️Variables:Domain Parameters

Abstract

Objectives: To report the follow-up and treatment results of cases with the diagnosis of familial exudative vitreoretinopathy (FEVR) in our clinic. Materials and Methods: We retrospectively reviewed the records of 19 eyes of 10 cases of FEVR that were followed up and some of them were treated in our clinic. Results: Nine male and one female patients with a mean age of 10.1 (3-30) years were included in the study. Seven patients had a family history of FEVR. Twelve eyes of 8 patients had laser photocoagulation to peripheral avascular areas, 3 patients had vitreoretinal surgery on one of their eyes three times. Unilateral total retinal detachment was determined in two patients at the initial visit and in three patients at the follow-up visits; because no improvement in the vision was expected, surgery was not done. Conclusion: FEVR is an inherited disease that can be detected in any age and can cause severe vision loss. These patients should be followed up throughout the life, and the essential treatment at the appropriate time can lead to partial visual recovery. (Turk J Ophthalmol 2014; 44: 370-3)

Özet

Amaç: Familyal eksudatif vitreoretinopati (FEVR) tanısı ile kliniğimizde takip edilen ve tedavileri uygulanan olguların sonuçlarını bildirmek amaçlanmaktadır. Gereç ve Yöntem: Kliniğimizde FEVR tanısı alan ve bazı olgularda tedavi uygulanmış 10 hastanın 19 gözüne ait kayıtlar geriye dönük olarak incelendi. Bulgular: Ortalama yaş 10,1 yıl olan (3-30) olan 9 erkek, 1 kadın hasta çalışmaya alındı. Yedi hastada FEVRe ait aile hikayesi bulunmaktaydı. Sekiz hastanın 12 gözüne periferik avasküler alanlara laser fotokoagülasyon, 3 hastanın birer gözüne üçer kez vitreoretinal cerrahi uygulandı. İki hastanın birer gözünde ilk başvuruda, üç hastanın birer gözünde takiplerde total retina dekolmanı saptanarak görme artışı beklenmediği için cerrahi girişim uygulanmadan takip edildi. Sonuç: Familyal eksudatif vitreoretinopati her yaşta saptanabilen ve ciddi derecede görme kaybına yol açabilen kalıtsal bir hastalıktır. Hayat boyunca takip edilmesi gereken bu hastalarda, uygun zamanda gerekli tedavi ile kısmi görsel başarı sağlanabilmektedir. (Turk J Ophthalmol 2014; 44: 370-3)

🔖

Cite This Article

KIR, N., CEBECİ, Z., BAYRAKTAR, Ş., YILDIZ, D. E. (2022). Familial exudative vitreoretinopathy: Follow-up and treatment results. Türk Oftalmoloji Dergisi, Cilt: 44 - Sayı: 5, 370–373. https://ajindex.com/articles/638026

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Ryan SJ. Retina (4th Ed). Philedelphia;Elsevier Mosby;2006: 1-3.
  2. Criswick VG, Schepens CL. Familial exudative vitreoretinopathy. Am J Ophthalmol. 1969;68:578-94.
  3. Shastry BS, Trese MT. Familial exudative vitreoretinopathy: further evidence for genetic heterogeneity. Am J Med Genet. 1997;69:217-8.
  4. Pendergast SD, Trese MT. Familial exudative vitreoretinopathy. Results of surgical management. Ophthalmology. 1998;105:1015-23.
  5. Shukla D, Singh J, Sudheer G, et al. Familial exudative vitreoretinopathy (FEVR). Clinical profile and management. Indian J Ophthalmol. 2003;51:323-8.
  6. Zhao S, Overbeek PA. Elevated TGFbeta signaling inhibits ocular vascular development. Dev Biol. 2001;237:45-53.
  7. Quiram PA, Drenser KA, Lai MM, Capone A Jr, Trese MT. Treatment of vascularly active familial exudative vitreoretinopathy with pegaptanib sodium (Macugen). Retina. 2008;28:8-12.
  8. Ikeda T, Fujikado T, Tano Y, et al. Vitrectomy for rhegmatogenous or tractional retinal detachment with familial exudative vitreoretinopathy. Ophthalmology. 1999;106:1081-5.
  9. Joshi MM, Ciaccia S, Trese MT, Capone A Jr. Posterior hyaloid contracture in pediatric vitreoretinopathies. Retina. 2006;26(Suppl 7):38-41.
  10. Dickinson JL, Sale MM, Passmore A, et al. Mutations in the NDP gene: contribution to Norrie disease, familial exudative vitreoretinopathy and retinopathy of prematurity. Clin Experiment Ophthalmol. 2006;34:682- 8. Ranchod TM, Ho LY, Drenser KA, Capone A Jr, Trese MT. Clinical presentation of familial exudative vitreoretinopathy. Ophthalmology. 2011;118:2070-5. Kaderli B. Familyal eksüdatif vitreoretinopati. Retina-Vitreus. 2012;20:120-4.
  11. Aktan G, Subasi M, Or M, Akbatur H. Results of treatment of familial exudative vitreoretinopathy. Annals of Ophthalmology. 2000;32: 212-8.
  12. Chen SN, Hwang JF, Lin CJ. Clinical characteristics and surgical management of familial exudative vitreoretinopathy-associated rhegmatogenous retinal detachment. Retina. 2012;32:220-5.